The incidence of the JAK2 V617F mutation in patients with idiopathic erythrocytosis - PubMed (original) (raw)
Comparative Study
Epub 2006 Feb 17.
- PMID: 16503548
Comparative Study
The incidence of the JAK2 V617F mutation in patients with idiopathic erythrocytosis
Melanie J Percy et al. Haematologica. 2006 Mar.
Abstract
Sixty-three patients with erythrocytosis exhibiting a range of erythropoietin levels were screened for the JAK2 V617F mutation. One patient (1.6%) was found to have this mutation, and has remained stable for 9 years, suggesting that the JAK2 V617F mutation is rare in patients with idiopathic erythrocytosis.
Similar articles
- A gain-of-function mutation of JAK2 in myeloproliferative disorders.
Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M, Skoda RC. Kralovics R, et al. N Engl J Med. 2005 Apr 28;352(17):1779-90. doi: 10.1056/NEJMoa051113. N Engl J Med. 2005. PMID: 15858187 - The effect of the JAK2 V617F mutation on PRV-1 expression.
Mnjoyan Z, Yoon D, Li J, Delhommeau F, Afshar-Kharghan V. Mnjoyan Z, et al. Haematologica. 2006 Mar;91(3):411-2. Epub 2006 Feb 17. Haematologica. 2006. PMID: 16503546 - The JAK2 V617F mutation is absent in patients with erythrocytosis due to high oxygen affinity hemoglobin variants.
McClure RF, Hoyer JD, Mai M. McClure RF, et al. Hemoglobin. 2006;30(4):487-9. doi: 10.1080/03630260600868147. Hemoglobin. 2006. PMID: 16987804 - Polycythemia vera: scientific advances and current practice.
Tefferi A, Spivak JL. Tefferi A, et al. Semin Hematol. 2005 Oct;42(4):206-20. doi: 10.1053/j.seminhematol.2005.08.003. Semin Hematol. 2005. PMID: 16210034 Review. - [Acquired mutation of JAK2 tyrosine kinase and polycythaemia vera].
Pargade V, Darnige L, Gaussem P. Pargade V, et al. Ann Biol Clin (Paris). 2006 Jan-Feb;64(1):3-9. Ann Biol Clin (Paris). 2006. PMID: 16420986 Review. French.
Cited by
- Dissecting Primary Erythrocytosis Among Polycythemia Patients Referred to an Indian Armed Forces Hospital.
Khurana H, Lakshman P, Kumar K, Jain A. Khurana H, et al. Indian J Hematol Blood Transfus. 2020 Jan;36(1):187-191. doi: 10.1007/s12288-019-01155-0. Epub 2019 Jul 8. Indian J Hematol Blood Transfus. 2020. PMID: 32158103 Free PMC article. - The relevance of a low JAK2V617F allele burden in clinical practice: a monocentric study.
Perricone M, Polverelli N, Martinelli G, Catani L, Ottaviani E, Zuffa E, Franchini E, Dizdari A, Forte D, Sabattini E, Cavo M, Vianelli N, Palandri F. Perricone M, et al. Oncotarget. 2017 Jun 6;8(23):37239-37249. doi: 10.18632/oncotarget.16744. Oncotarget. 2017. PMID: 28422729 Free PMC article. - Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations.
Camps C, Petousi N, Bento C, Cario H, Copley RR, McMullin MF, van Wijk R, Ratcliffe PJ, Robbins PA, Taylor JC; WGS500 Consortium. Camps C, et al. Haematologica. 2016 Nov;101(11):1306-1318. doi: 10.3324/haematol.2016.144063. Epub 2016 Sep 20. Haematologica. 2016. PMID: 27651169 Free PMC article. - Clinical utility gene card for: familial erythrocytosis.
Hussein K, Percy M, McMullin MF. Hussein K, et al. Eur J Hum Genet. 2012 May;20(5). doi: 10.1038/ejhg.2011.252. Epub 2012 Jan 25. Eur J Hum Genet. 2012. PMID: 22274579 Free PMC article. No abstract available. - JAK2 V617F mutation is rare in idiopathic erythrocytosis: a difference from polycythemia vera.
Yoshinaga K, Mori N, Wang YH, Tomita K, Shiseki M, Motoji T. Yoshinaga K, et al. Int J Hematol. 2008 Jul;88(1):82-87. doi: 10.1007/s12185-008-0103-6. Epub 2008 Jun 6. Int J Hematol. 2008. PMID: 18528646 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous